Tilray Brands, Inc.

TLRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016
Revenue $43.1M $20.5M $12.6M
Cost of Revenue $28.9M $9.2M $10.0M
Gross Profit $14.3M $11.4M $2.7M
Gross Margin 33.1% 55.4% 21.1%
Operating Expenses
Research & Development $5.9M $3.2M $1.1M
SG&A Expense $48.6M $7.5M $4.9M
Operating Income $-57.8M $-7.5M $-7.0M
Operating Margin -134.1% -36.5% -55.7%
Interest Expense $5.7M $693.0K $772.0K
Pretax Income $-72.2M $-7.8M $-7.9M
Income Tax Expense $-4.5M
Net Income $-67.7M $-7.8M $-7.9M
Net Margin -157.0% -38.0% -62.3%
EPS (Basic) $-0.82 $-0.10 $-0.11
EPS (Diluted) $-0.82 $-0.10 $-0.11
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 2 of 2 Older →